Fact CheckerSign in

NCT05431127Completed

High Dose Inspiratory Muscle Training in LOPD

High-dose Inspiratory Muscle Training (IMT) in Late-onset Pompe Disease (LOPD)

Source: ClinicalTrials.gov · Last updated 1 Oct 2025

Brief summary (registry, in English)

Study Objectives: 1) assess the safety and feasibility of high-dose inspiratory muscle training (IMT) delivered remotely in Late-onset Pompe Disease (LOPD) and 2) determine its effects on respiratory and patient-reported outcomes.

Status (registry)
Completed
Study type
Interventional
Enrollment
34 (actual)
First submitted
21 Jun 2022
Start date
19 Jul 2022
Primary completion date
1 Jan 2025
Lead sponsor
Duke University
NCT number
NCT05431127

What you commit to

  • Study type: Interventional
  • Participants enrolled: 34
  • From 19 Jul 2022 to the primary completion date, 1 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Prior history of gene therapy for LOPD

Other illness

  • Presence of medical comorbidities that prevent meaningful study participation (e.g., COPD GOLD III-IV, significant mental illness, dementia)

Other

  • Use of continuous invasive or non-invasive ventilation while awake
  • Inability to give legally effective consent
  • Inability to read and understand English

Who the study is looking for

  • Age ≥ 18 years
  • Confirmed diagnosis of LOPD
  • MIP \>50% of predicted for sex and age
  • Stable on current Pompe disease treatment regimen \>6 months
  • Able to follow directions for study participation
  • Access to computer and smartphone/tablet with reliable internet connection for video visits and sensor-based respiratory technologies

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Duke University Medical Center
Coordinator of this site? Confirm its status
DurhamUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.